Federal investigators say that a Chinese drug manufacturer, previously on the Food and Drug Administration’s list of preapproved foreign companies allowed to import GLP-1 ingredients, was able to bring in batches of the weight loss drug from an unauthorized supplier and introduce the substance of unknown origin into the U.S. drug supply. In September 2025,…